Nabi files liver infection drug application(第一个免疫球蛋白治疗HBV再感染...) - 精华资料

15/10/02说明：此前论坛服务器频繁出错，现已更换服务器。今后论坛继续数据库备份，不备份上传附件。

肝胆相照论坛 › 论坛 › 精华资料 › 存档 1 › Nabi files liver infection drug application(第一个免 ...

查看: 850\|回复: 4	Nabi files liver infection drug application(第一个免疫球蛋白治疗HBV再感染...) [复制链接]

liver411

管理员

Rank: 1

现金: 222032 元
精华: 285
帖子: 67620
注册时间: 2001-11-10
最后登录: 2023-5-7

元帅勋章功勋会员管理员或超版荣誉之星勤于助新龙的传人大财主勋章白衣天使旺旺勋章心爱宝宝携手同心有声有色东北版美食大使幸福四叶草翡翠丝带健康之翼幸福风车恭喜发财人中之龙

1楼

发表于 2002-11-27 19:33

November 26, 2002 14:44 EST Tuesday

Nabi Biopharmaceuticals (Nasdaq: NABI) said it submitted a Biologics License Application to the U.S. Food and Drug Administration for the use of Nabi-HB intravenous hepatitis B immune globulin to prevent liver transplant patients from suffering re-infection of their transplanted livers with hepatitis B virus.

The company said the filing "represents a significant milestone" for the company. If the treatment is approved, it would represent the first hepatitis B immune globulin therapy approved by the FDA to help protect patients from HBV re-infection following liver transplant surgery, according to a release.

The product is produced at the Nabi Biopharmaceuticals' manufacturing plant in Boca Raton.

God Made Everything That Has Life. Rest Everything Is Made In China